The impact of blockchain technology on brand loyalty in the context of sustainability in fashion industry
Bu tez size mi ait?
Bu kayıt toplu arşivden geldi. Sizinse profilinize bağlayın.
Özet (EN)
This study, which was carried out as qualitative research, aimed to search the effects of blockchain technology on the brand loyalty acquisition of fashion brands as an era of use in the fashion industry in the context of sustainability. The in-depth interview method was used as a qualitative research method. Seven basic semi-structured questions were formed by evaluating the literature research, sector professionals working professionally in the context of sustainability in the fashion industry and interested in blockchain technology were identified, and interviews were identified conducted with them. It has been made inference that the use of blockchain technology has a positive effect on gaining brand loyalty in the fashion industry in the context of sustainability. In this respect, it has been developed a new conceptual model for future researches.
Yazar
Elyesa Eyinç
Bu Yayına Nasıl Atıf Yapılır
Elyesa Eyinç (Master Thesis). The impact of blockchain technology on brand loyalty in the context of sustainability in fashion industry, 2021, Yeditepe University.
Anahtar Kelimeler
Lisans
Tüm Hakları Saklıdır
Bu eser belirtilen lisans koşulları altında paylaşılmaktadır.
Yeditepe University tezlerinden daha fazlası
- Studies on cyclodextrin complexation of a poorly water soluble anti-hyperlipidemic drug, tablet formulation and characterization(2021)
- Washington ambassadors in Turkish-US relations (1927-1960)(2023)
- Metamorphosis of female voices: A study of the violation of women in Greek and Roman mythology and feminist rewritings reclaiming the narrative(2022)
- Knowledge distillation with foundation models for image segmentation(2023)
- The relationship between machiavelism, grandiose and vulnerable narcissism, and loneliness among white collar workers(2023)
- Evaluation of drug-drug interaction checkers along clinically relevant adverse drug events in oncology and hematology pediatric patients(2023)